Childhood drug-resistant TB rife in Cape Town

One in eight children with confirmed TB has drug-resistant TB in Cape Town, South Africa, according to a surveillance study of childhood TB drug-resistance, presented by Professor Simon Schaaf at the 46th Union World Conference on Lung Health held in Cape Town from 2 to 6 December 2015.

Drug resistance

Twenty per cent of multi-drug resistant TB cases were also found to be resistant to ofloxacin, which has important implications for the second-line treatment regimen in South Africa, which also contains the drug.

Ofloxacin is a broad-spectrum antibiotic and the active ingredient of Exocin, Octin, Tafloc, Tarivid and Zanocin.

Read: Drug resistant TB remains a crisis

The findings come from a prospective surveillance study conducted from March 2013 to February 2015 at the Tygerberg Children’s Hospital in Cape Town.

Drug-sensitivity was conducted using line probe assay for isoniazid and rifampicin (antibiotics used as first-line treatment of tuberculosis) and on the first isolate from each child under 13 years of age who had culture-confirmed TB.

Further phenotypic drug-sensitivity testing (tests to determine if the person is resistant to the drug) was done if rifampicin resistance was found.

If an Xpert MTB/RIF test was positive and indicated rifampicin resistance, but culture-negative, no further drug-sensitivity testing was possible.

Read: SA in dark on drug resistant TB

Results were compared with five previous two-year surveys conducted at the same hospital.

Of the 292 children who had culture- or Xpert MTB/RIF-positive results for TB who were included in the study, 16 (5.5%) were found to be Xpert-positive but culture negative and were not included in the analysis. The median age was 35.5 months (IQR: 14 – 82 months) and 49% (n=143) were male.

Comparison of results

12.7% (n=35) were diagnosed with drug-resistant TB.

Four per cent (n=11) died while in hospital, eight of whom died in within the first week of hospital admission.

15.5% (n=41) of the 95.7% of the culture-confirmed TB cases that were tested for HIV, were found to be HIV-positive.

Read: Is TB spinning out of control in SA?

When comparing the results from the 2013-2015 survey to the five previous drug-resistance surveys conducted at the hospital, of the cases found to be drug-resistant, there was a significant decrease in the proportion of isoniazid mono-resistance from 2.5 % in 2013-2015 compared to 7.7% in 2005-2007 (p=0.0007).

Rifampicin mono-resistance increase from no cases in 2003-2005 to 2.9% (n=8) of cases in 2013-2015 (p=0.002).

Read: New antibiotic could overcome drug resistant TB

Although there has been a significant twofold decrease in the proportion of multidrug-resistant (MDR) cases between 2007 to 2009 (8.9%) and 2011 to 2013 (4.6%) [OR: 2.01; 95% CI: 1.04-3.88, p=0.04], this decrease was not sustained in the latest survey, when it rose to 7.2%.

There had been a significant decrease in the number of cases who had previously been on TB treatment, from 22.3% (n=65) in 2005-2007 to 10.1% (n=28) in 2013-15; OR 2.55 (95% CI: 1.58 – 4.11, p<0.0001).

HIV prevalence decreased significantly from 29% to 15.5% between the 2005-2007 survey and the 2013 to 2015 survey (OR1.56; 95% CI:1.01 –4.11, p<0.05). There was also a significant increase in the proportion of children tested for HIV over the same period from 59% (n=174) to 95.7% (n=264). 

Read more: 

Why children are dying of TB in Uganda 

WHO clarifies 'totally' drug resistant TB 

Doctors save child who got drug-resistant TB in India

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24